Egalet Corporation
Latest round
- Series C
Last raised
- Sep 2013
Total raised
- $44M
Investors
- 10
About Egalet Corporation
Egalet Corporation specializes in creating pharmaceutical products aimed at pain management. Founded in 1995 in Wayne, US, the company has undergone several strategic adjustments to enhance its offerings.4 mn from the public market.Egalet Corporation specializes in the development and commercialization of innovative pharmaceutical products, particularly in pain management. The company’s core offerings are designed to provide solutions for patients requiring effective pain relief while minimizing the risks of misuse and abuse. Their flagship product, a unique formulation of an opioid analgesic, is engineered to deter tampering and misuse, addressing critical concerns in pain management. Egalet's products are primarily targeted toward healthcare providers, including pain specialists and general practitioners, as well as patients with chronic pain conditions.Egalet Corporation generates revenue through direct sales of its pharmaceutical products to healthcare providers and distributors.06 mn. The company’s transaction structure typically involves B2B sales where products are sold through wholesale distributors, pharmacies, and directly to healthcare institutions. Revenue is derived from prescription sales of its proprietary formulations, with terms negotiated in accordance with market conditions and the specific needs of its clients. Pricing plans are established based on the value proposition of their products, considering factors such as efficacy and safety profiles, particularly for their trademarked formulations.Egalet Corporation is strategically poised for future growth, focusing on the development of new pharmaceutical products aimed at expanding its pain management portfolio. The company is also looking to expand its geographical footprint into additional international markets several years ahead, enhancing its existing distribution channels.
Who invested in Egalet Corporation
10 investors across 3 rounds
See all investors in Egalet Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Egalet Corporation
Who invested in Egalet Corporation?
Egalet Corporation has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Egalet Corporation raised?
Egalet Corporation has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Egalet Corporation last raise money?
Egalet Corporation's most recent round on record is a Series C, in Sep 2013.
What does Egalet Corporation do?
Egalet Corporation specializes in creating pharmaceutical products aimed at pain management.
Where is Egalet Corporation headquartered?
Egalet Corporation is headquartered in Wayne, US.
Which VCs invest in companies like Egalet Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Egalet Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Egalet Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.